NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 112,100 shares, an increase of 26.0% from the February 28th total of 89,000 shares. Based on an average trading volume of 226,500 shares, the days-to-cover ratio is currently 0.5 days. Currently, 2.7% of the company’s stock are short sold.

NovaBay Pharmaceuticals Stock Up 0.0 %

Shares of NYSEAMERICAN:NBY traded up $0.00 during mid-day trading on Tuesday, hitting $0.59. 112,460 shares of the company traded hands, compared to its average volume of 208,406. NovaBay Pharmaceuticals has a 12-month low of $0.36 and a 12-month high of $9.08. The stock has a market cap of $2.46 million, a price-to-earnings ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.